Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Mar, 2017 | Pages:
114 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Notes:
Sales, means the sales volume of Type 1 Diabetes Drugs
Revenue, means the sales value of Type 1 Diabetes Drugs
This report studies Type 1 Diabetes Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Novo Nordisk
Sanofi
Eli Lily
AstraZeneca
Astellas Pharma
Merck
Perle Biosciences
Pfizer
Merrion Pharmaceutical
Boehringer Ingelheim
XOMA
Osiris Therapeutics
GlaxoSmithKline
Generex Biotechnology
Gan & Lee Pharmaceuticals
Adocia
Baxalta
Tolerio
Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Fast-Acting Insulin
Intermediate-Acting Insulin
Long-Acting Insulin
Other
Split by Application, this report focuses on consumption, market share and growth rate of Type 1 Diabetes Drugs in each application, can be divided into
Hospitals
Clinics
Table of Contents
China Type 1 Diabetes Drugs Market Research Report 2017
1 Type 1 Diabetes Drugs Market Overview
1.1 Product Overview and Scope of Type 1 Diabetes Drugs
1.2 Type 1 Diabetes Drugs Segment by Type
1.2.1 China Production Market Share of Type 1 Diabetes Drugs Type in 2015
1.2.2 Fast-Acting Insulin
1.2.3 Intermediate-Acting Insulin
1.2.4 Long-Acting Insulin
1.2.5 Other
1.3 Applications of Type 1 Diabetes Drugs
1.3.1 Type 1 Diabetes Drugs Consumption Market Share by Application in 2015
1.3.2 Hospitals
1.3.3 Clinics
1.4 China Market Size (Value) of Type 1 Diabetes Drugs (2012-2022)
1.5 China Type 1 Diabetes Drugs Status and Outlook
1.6 Government Policies
2 China Type 1 Diabetes Drugs Market Competition by Manufacturers
2.1 China Type 1 Diabetes Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Type 1 Diabetes Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Type 1 Diabetes Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Type 1 Diabetes Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Type 1 Diabetes Drugs Market Competitive Situation and Trends
2.5.1 Type 1 Diabetes Drugs Market Concentration Rate
2.5.2 Type 1 Diabetes Drugs Market Share of Top 3 and Top 5 Manufacturers
3 China Type 1 Diabetes Drugs Manufacturers Profiles/Analysis
3.1 Novo Nordisk
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Type 1 Diabetes Drugs Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 Novo Nordisk Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Sanofi
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Type 1 Diabetes Drugs Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Sanofi Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Eli Lily
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Type 1 Diabetes Drugs Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Eli Lily Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 AstraZeneca
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Type 1 Diabetes Drugs Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 AstraZeneca Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Astellas Pharma
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Type 1 Diabetes Drugs Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Astellas Pharma Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Merck
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Type 1 Diabetes Drugs Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 Merck Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Perle Biosciences
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Type 1 Diabetes Drugs Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 Perle Biosciences Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Pfizer
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Type 1 Diabetes Drugs Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Pfizer Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Merrion Pharmaceutical
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Type 1 Diabetes Drugs Product Type, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Merrion Pharmaceutical Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Boehringer Ingelheim
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Type 1 Diabetes Drugs Product Type, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 Boehringer Ingelheim Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 XOMA
3.12 Osiris Therapeutics
3.13 GlaxoSmithKline
3.14 Generex Biotechnology
3.15 Gan & Lee Pharmaceuticals
3.16 Adocia
3.17 Baxalta
3.18 Tolerio
4 China Type 1 Diabetes Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Type 1 Diabetes Drugs Capacity, Production and Growth (2012-2017)
4.2 China Type 1 Diabetes Drugs Revenue and Growth (2012-2017)
4.3 China Type 1 Diabetes Drugs Production, Consumption, Export and Import (2012-2017)
5 China Type 1 Diabetes Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Type 1 Diabetes Drugs Production and Market Share by Type (2012-2017)
5.2 China Type 1 Diabetes Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Type 1 Diabetes Drugs Price by Type (2012-2017)
5.4 China Type 1 Diabetes Drugs Production Growth by Type (2012-2017)
6 China Type 1 Diabetes Drugs Market Analysis by Application
6.1 China Type 1 Diabetes Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Type 1 Diabetes Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries
7 ChinaType 1 Diabetes Drugs Market Analysis by Regions (Provinces)
7.1 China Type 1 Diabetes Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Type 1 Diabetes Drugs Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Type 1 Diabetes Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Type 1 Diabetes Drugs Sales Price by Regions (Provinces)(2012-2017)
7.2 China Type 1 Diabetes Drugs Consumption by Regions (Provinces)(2012-2017)
7.3 China Type 1 Diabetes Drugs Production, Consumption, Export and Import (2012-2017)
8 Type 1 Diabetes Drugs Manufacturing Cost Analysis
8.1 Type 1 Diabetes Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Type 1 Diabetes Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Type 1 Diabetes Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Type 1 Diabetes Drugs Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 China Type 1 Diabetes Drugs Market Forecast (2017-2022)
12.1 China Type 1 Diabetes Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Type 1 Diabetes Drugs Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Type 1 Diabetes Drugs Production Forecast by Type (2017-2022)
12.4 China Type 1 Diabetes Drugs Consumption Forecast by Application (2017-2022)
12.5 China Type 1 Diabetes Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Type 1 Diabetes Drugs Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Type 1 Diabetes Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Type 1 Diabetes Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Type 1 Diabetes Drugs Price Forecast (2017-2022)
13 Research Findings and Conclusion
14 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Type 1 Diabetes Drugs
Figure China Production Market Share of Type 1 Diabetes Drugs by Type in 2015
Figure Product Picture of Fast-Acting Insulin
Table Major Manufacturers of Fast-Acting Insulin
Figure Product Picture of Intermediate-Acting Insulin
Table Major Manufacturers of Intermediate-Acting Insulin
Figure Product Picture of Long-Acting Insulin
Table Major Manufacturers of Long-Acting Insulin
Figure Product Picture of Other
Table Major Manufacturers of Other
Table Type 1 Diabetes Drugs Consumption Market Share by Application in 2015
Figure Hospitals Examples
Figure Clinics Examples
Figure China Type 1 Diabetes Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table China Type 1 Diabetes Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Type 1 Diabetes Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Type 1 Diabetes Drugs Capacity of Key Manufacturers in 2015
Figure China Type 1 Diabetes Drugs Capacity of Key Manufacturers in 2016
Table China Type 1 Diabetes Drugs Production of Key Manufacturers (2015 and 2016)
Table China Type 1 Diabetes Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Type 1 Diabetes Drugs Production Share by Manufacturers
Figure 2016 Type 1 Diabetes Drugs Production Share by Manufacturers
Table China Type 1 Diabetes Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Type 1 Diabetes Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Type 1 Diabetes Drugs Revenue Share by Manufacturers
Table 2016 China Type 1 Diabetes Drugs Revenue Share by Manufacturers
Table China Market Type 1 Diabetes Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Type 1 Diabetes Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Type 1 Diabetes Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Type 1 Diabetes Drugs Product Type
Figure Type 1 Diabetes Drugs Market Share of Top 3 Manufacturers
Figure Type 1 Diabetes Drugs Market Share of Top 5 Manufacturers
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Type 1 Diabetes Drugs Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Type 1 Diabetes Drugs Market Share (2012-2017)
Table Eli Lily Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lily Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lily Type 1 Diabetes Drugs Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Type 1 Diabetes Drugs Market Share (2012-2017)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Pharma Type 1 Diabetes Drugs Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Type 1 Diabetes Drugs Market Share (2012-2017)
Table Perle Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Perle Biosciences Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Perle Biosciences Type 1 Diabetes Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Type 1 Diabetes Drugs Market Share (2012-2017)
Table Merrion Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merrion Pharmaceutical Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merrion Pharmaceutical Type 1 Diabetes Drugs Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Type 1 Diabetes Drugs Market Share (2012-2017)
Table XOMA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Osiris Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Generex Biotechnology Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Adocia Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxalta Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tolerio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Type 1 Diabetes Drugs Capacity, Production and Growth (2012-2017)
Figure China Type 1 Diabetes Drugs Revenue (Million USD) and Growth (2012-2017)
Table China Type 1 Diabetes Drugs Production, Consumption, Export and Import (2012-2017)
Table China Type 1 Diabetes Drugs Production by Type (2012-2017)
Table China Type 1 Diabetes Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Type 1 Diabetes Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Type 1 Diabetes Drugs by Type
Table China Type 1 Diabetes Drugs Revenue by Type (2012-2017)
Table China Type 1 Diabetes Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Type 1 Diabetes Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Type 1 Diabetes Drugs by Type
Table China Type 1 Diabetes Drugs Price by Type (2012-2017)
Figure China Type 1 Diabetes Drugs Production Growth by Type (2012-2017)
Table China Type 1 Diabetes Drugs Consumption by Application (2012-2017)
Table China Type 1 Diabetes Drugs Consumption Market Share by Application (2012-2017)
Figure China Type 1 Diabetes Drugs Consumption Market Share by Application in 2015
Table China Type 1 Diabetes Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Type 1 Diabetes Drugs Consumption Growth Rate by Application (2012-2017)
Table China Type 1 Diabetes Drugs Production by Regions (Provinces)(2012-2017)
Table China Type 1 Diabetes Drugs Production Market Share by Regions (Provinces)(2012-2017)
Table China Type 1 Diabetes Drugs Production Value by Regions (Provinces)(2012-2017)
Table China Type 1 Diabetes Drugs Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Type 1 Diabetes Drugs Sales Price by Regions (Provinces)(2012-2017)
Table China Type 1 Diabetes Drugs Consumption by Regions (Provinces)(2012-2017)
Table China Type 1 Diabetes Drugs Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Type 1 Diabetes Drugs Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Type 1 Diabetes Drugs
Figure Manufacturing Process Analysis of Type 1 Diabetes Drugs
Figure Type 1 Diabetes Drugs Industrial Chain Analysis
Table Raw Materials Sources of Type 1 Diabetes Drugs Major Manufacturers in 2015
Table Major Buyers of Type 1 Diabetes Drugs
Table Distributors/Traders List
Figure China Type 1 Diabetes Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Type 1 Diabetes Drugs Revenue and Growth Rate Forecast (2017-2022)
Table China Type 1 Diabetes Drugs Production, Import, Export and Consumption Forecast (2017-2022)
Table China Type 1 Diabetes Drugs Production Forecast by Type (2017-2022)
Table China Type 1 Diabetes Drugs Consumption Forecast by Application (2017-2022)
Table China Type 1 Diabetes Drugs Production Forecast by Regions (Provinces)(2017-2022)
Table China Type 1 Diabetes Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Type 1 Diabetes Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
